Aspira Women's Health Files 2024 10-K
Ticker: AWHL · Form: 10-K · Filed: Mar 27, 2025 · CIK: 926617
Sentiment: neutral
Topics: 10-K, annual-report, diagnostics
TL;DR
Aspira Women's Health filed its 2024 10-K. Check financials.
AI Summary
Aspira Women's Health Inc. filed its 2024 10-K on March 27, 2025, reporting on its fiscal year ending December 31, 2024. The company, formerly known as Vermillion, Inc. and Ciphergen Biosystems Inc., is involved in in vitro and in vivo diagnostic substances. The filing details its financial performance and business operations for the period.
Why It Matters
This filing provides a comprehensive overview of Aspira Women's Health's financial health and strategic direction for the past fiscal year, crucial for investors and stakeholders to assess the company's performance and future prospects.
Risk Assessment
Risk Level: medium — As a company in the diagnostic substances sector, Aspira Women's Health faces risks related to regulatory approvals, market competition, and technological advancements.
Key Players & Entities
- Aspira Women's Health Inc. (company) — Filer
- 2024-12-31 (date) — Fiscal Year End
- 2025-03-27 (date) — Filing Date
- Vermillion, Inc. (company) — Former Company Name
- Ciphergen Biosystems Inc (company) — Former Company Name
- 330595156 (dollar_amount) — EIN
- DE (location) — State of Incorporation
- 12117 BEE CAVES ROAD BUILDING THREE SUITE 100 (location) — Business Address
- AUSTIN (location) — City
- TX (location) — State
FAQ
What is Aspira Women's Health Inc.'s primary business activity?
Aspira Women's Health Inc. is involved in 'IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES' as indicated by its Standard Industrial Classification code.
When did Aspira Women's Health Inc. file its 10-K report for the fiscal year 2024?
The 10-K report for the fiscal year ending December 31, 2024, was filed on March 27, 2025.
What were some of the previous names of Aspira Women's Health Inc.?
The company was formerly known as VERMILLION, INC. and CIPHERGEN BIOSYSTEMS INC.
Where is Aspira Women's Health Inc. headquartered?
The company's business and mailing address is 12117 BEE CAVES ROAD BUILDING THREE, SUITE 100, AUSTIN, TX 78738.
What is the SEC file number for Aspira Women's Health Inc.'s 10-K filing?
The SEC file number for this 10-K filing is 001-34810.
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on March 27, 2025 regarding Aspira Women's Health Inc. (AWHL).